https://explicyte.com/poster/impact-of-immune-contexture-on-immunotherapy-response-in-nsclc-insights-from-multiplex-ihc-and-machine-learning-based-phenotyping/ 2026-10-28T13:03:33+00:00 https://explicyte.com/wp-content/uploads/2026/07/AACR-2025-Impact-of-Immune-Contexture-on-Immunotherapy-Response-in-NSCLC-Insights-from-Multiplex-IHC-and-Machine-Learning-Based-Phenotyping-1.jpg https://explicyte.com/wp-content/uploads/2026/07/immune-contexture-IHC-panel-cd8-panck-1.jpg https://explicyte.com/wp-content/uploads/2026/07/immune-contexture-tls-macrophage-panel-IHF-1.jpg https://explicyte.com/wp-content/uploads/2026/07/AACR-2025-Immune-Context-Abstract-PRINT-pdf.jpg https://explicyte.com/wp-content/uploads/2026/07/AACR-2025-Immune-Context-Abstract-PRINT-pdf.jpg https://explicyte.com/wp-includes/images/media/document.png https://explicyte.com/poster/ccr8-tregs-tls-spatial-atlas-esmo-2026/ 2026-10-21T11:54:07+00:00 https://explicyte.com/wp-content/uploads/2026/10/Large-scale-spatial-atlas-of-CCR8-expression-across-TLS-maturity-in-solid-tumors.jpg https://explicyte.com/wp-content/uploads/2026/10/ESMO2026_4413P_CCR8_TLS_GR-1-pdf.jpg https://explicyte.com/wp-content/uploads/2026/10/ESMO2026_4413P_CCR8_TLS_GR-1-pdf.jpg https://explicyte.com/wp-includes/images/media/document.png https://explicyte.com/poster/stamp-xenium-cytokine-release-syndrome/ 2026-09-29T18:06:50+00:00 https://explicyte.com/wp-content/uploads/2026/09/STAMP-Xenium-Single-Cell-Profiling-of-Cytokine-Release-Syndrome.jpg https://explicyte.com/wp-content/uploads/2026/09/Poster_STAMPvPEG-final-web2-pdf.jpg https://explicyte.com/wp-content/uploads/2026/09/Poster_STAMPvPEG-final-web2-pdf.jpg https://explicyte.com/wp-includes/images/media/document.png https://explicyte.com/poster/analysis-of-spatial-atlas-of-adc-targets-in-immunotherapy-treated-nsclc-to-link-compartment-specific-target-expression-with-tumor-immune-contexture-clinical-outcome-and-on-treatment-remodeling/ 2026-07-15T13:05:23+00:00 https://explicyte.com/wp-content/uploads/2026/07/integrated-spatial-ADC-target-atlas-across-NSCLC-bladder-gastric-and-endometrial-cancers.jpg https://explicyte.com/poster/tertiary-lymphoid-structures-as-predictors-of-immune-checkpoint-inhibitor-efficacy-in-nsclc-the-development-of-an-ex-vivo-model-for-precision-medicine/ 2026-07-15T12:24:45+00:00 https://explicyte.com/wp-content/uploads/2026/07/AACR-2025-Poster-Tertiary-Lymphoid-Structures-as-Predictors-of-Immune-checkpoint-inhibitor-efficacy-in-NSCLC.jpg https://explicyte.com/wp-content/uploads/2026/07/AACR-2025-TLS-Abstract-AB_PRINT-pdf.jpg https://explicyte.com/wp-content/uploads/2026/07/AACR-2025-TLS-Abstract-AB_PRINT-pdf.jpg https://explicyte.com/wp-includes/images/media/document.png https://explicyte.com/poster/ccr8-positive-tregs-and-their-correlation-with-immunotherapy-response-in-advanced-non-small-cell-lung-cancer-nsclc/ 2026-07-15T11:49:43+00:00 https://explicyte.com/wp-content/uploads/2026/07/Asco-2025-Explicyte-poster-CCR8-positive-Tregs-and-Their-Correlation-with-Immunotherapy.png https://explicyte.com/wp-content/uploads/2026/07/ASCO-2025-CCR8-final-print-pdf.jpg https://explicyte.com/wp-content/uploads/2026/07/ASCO-2025-CCR8-final-print-pdf.jpg https://explicyte.com/wp-includes/images/media/document.png https://explicyte.com/poster/high-dimensional-spatial-profiling-of-the-tumor-immune-microenvironment-tme-in-recurrent-metastatic-head-and-neck-squamous-cell-carcinoma-hnscc-reveals-predictive-biomarkers-of-immunotherapy/ 2026-07-15T10:01:52+00:00 https://explicyte.com/wp-content/uploads/2026/07/High-Dimensional-Spatial-Profiling-of-the-Tumor-Immune-Microenvironment.jpg https://explicyte.com/wp-content/uploads/2026/07/High-Dimensional-Spatial-Profiling-of-the-Tumor-Immune-Microenvironment-in-in-Recurrent-HNSCC-pdf.jpg https://explicyte.com/wp-content/uploads/2026/07/High-Dimensional-Spatial-Profiling-of-the-Tumor-Immune-Microenvironment-in-in-Recurrent-HNSCC-pdf.jpg https://explicyte.com/wp-includes/images/media/document.png https://explicyte.com/poster/spatial-transcriptomics-reveal-crucial-determinants-of-immune-exclusion-in-non-small-cell-lung-cancer-an-analysis-of-the-precision-medicine-bip-study/ 2026-07-15T09:34:39+00:00 https://explicyte.com/wp-content/uploads/2026/06/ASCO-2025-Explicyte-poster-Spatial-transcriptomics-reveal-crucial-determinants-of-immune-exclusion.png https://explicyte.com/wp-content/uploads/2026/06/Asco-BIP-final-print-pdf.jpg https://explicyte.com/wp-content/uploads/2026/06/Asco-BIP-final-print-pdf.jpg https://explicyte.com/wp-includes/images/media/document.png https://explicyte.com/poster/tumor-cell-ny-eso-1-expression-predicts-poor-response-to-pd-1-pd-l1-blockade-in-nsclc/ 2026-07-15T09:34:03+00:00 https://explicyte.com/wp-content/uploads/2026/07/Tumor-cell-NY-ESO-1-Expression-Predicts-Poor-Response-to-PD-1-PD-L1-Blockade-NSCLC.jpg https://explicyte.com/wp-content/uploads/2026/07/Tumor-cell-NY-ESO-1-Expression-Predicts-Poor-Response-to-PD-1-PD-L1-Blockade-in-NSCLC-pdf.jpg https://explicyte.com/wp-content/uploads/2026/07/Tumor-cell-NY-ESO-1-Expression-Predicts-Poor-Response-to-PD-1-PD-L1-Blockade-in-NSCLC-pdf.jpg https://explicyte.com/wp-includes/images/media/document.png https://explicyte.com/poster/high-grade-serous-ovarian-cancer-ascites-exhibit-an-impaired-immune-environment-immunosuppressive-protumoral-detrimental-to-the-immune-response/ 2026-07-10T14:19:15+00:00 https://explicyte.com/wp-content/uploads/2026/07/Poster-AACR-IO-2025-High-grade-serous-ovarian-cancer-ascites-exhibit-an-impaired-immune-environment-immunosuppressive-protumoral-%E2%80%93-detrimental-to-the-immune-response.jpg https://explicyte.com/wp-content/uploads/2026/07/Ascites_Poster_AACR-2025-pdf.jpg https://explicyte.com/wp-content/uploads/2026/07/Ascites_Poster_AACR-2025-pdf.jpg https://explicyte.com/wp-includes/images/media/document.png https://explicyte.com/poster/enhanced-anti-tumor-response-to-anti-angiogenic-hypoxia-regulating-therapies-in-combination-with-immune-checkpoint-blockade-in-a-murine-model-of-renal-carcinoma/ 2026-07-10T14:13:10+00:00 https://explicyte.com/wp-content/uploads/2026/07/poster-AACR-IO-2025-Enhanced-anti-tumor-response-to-anti-angiogenic-hypoxia-regulating-therapies-in-combination-with-immune-checkpoint-blockade-in-a-murine-model-of-renal-carcinoma.jpg https://explicyte.com/wp-content/uploads/2026/07/Renca_Poster_AACR-2025-pdf.jpg https://explicyte.com/wp-content/uploads/2026/07/Renca_Poster_AACR-2025-pdf.jpg https://explicyte.com/wp-includes/images/media/document.png https://explicyte.com/poster/cancer-associated-fibroblasts-promote-t-cell-exclusion-and-resistance-to-immunotherapy-in-non-small-cell-lung-cancer-with-tertiary-lymphoid-structures/ 2026-07-10T13:52:01+00:00 https://explicyte.com/wp-content/uploads/2026/07/Poster-AACR-2023-Cancer-associated-fibroblasts-promote-T-cell-exclusion-resistance-immunotherapy-in-non-small-cell-lung-cancer.jpg https://explicyte.com/wp-content/uploads/2026/07/Poster-AACR-2023_Fibroblasts_EXP-pdf.jpg https://explicyte.com/wp-content/uploads/2026/07/Poster-AACR-2023_Fibroblasts_EXP-pdf.jpg https://explicyte.com/wp-includes/images/media/document.png https://explicyte.com/poster/trop2-expression-and-response-to-immune-checkpoint-inhibition-in-patients-with-advanced-non-small-cell-lung-cancer/ 2026-07-10T13:50:47+00:00 https://explicyte.com/wp-content/uploads/2026/07/Poster_ASCO2023_TROP2-expression-response-immune-checkpoint-inhibition-patients-advanced-non-small-cell-lung-cancer.jpg https://explicyte.com/wp-content/uploads/2026/07/Poster_ASCO2023_TROP2-expression-response-immune-checkpoint-inhibition-patients-advanced-non-small-cell-lung-cancer-pdf.jpg https://explicyte.com/wp-content/uploads/2026/07/Poster_ASCO2023_TROP2-expression-response-immune-checkpoint-inhibition-patients-advanced-non-small-cell-lung-cancer-pdf.jpg https://explicyte.com/wp-includes/images/media/document.png https://explicyte.com/poster/profiling-of-immune-cell-components-and-soluble-factors-in-ovarian-cancer-ascites-highlights-impaired-immune-environment/ 2026-07-10T13:40:24+00:00 https://explicyte.com/wp-content/uploads/2026/07/AACR-2023-Profiling-immune-cell-components-soluble-factors-ovarian-cancer-ascites.jpg https://explicyte.com/wp-content/uploads/2026/07/AACR-2023-Profiling-immune-cell-components-soluble-factors-ovarian-cancer-ascites-pdf.jpg https://explicyte.com/wp-content/uploads/2026/07/AACR-2023-Profiling-immune-cell-components-soluble-factors-ovarian-cancer-ascites-pdf.jpg https://explicyte.com/wp-includes/images/media/document.png https://explicyte.com/poster/indoleamine-23-dioxygenase-1-is-expressed-in-tertiary-lymphoid-structures-and-associated-with-improved-outcome-in-patients-with-advanced-non-small-cell-lung-cancer-treated-with-anti-pd1-pdl1-inhibito/ 2026-07-10T13:34:59+00:00 https://explicyte.com/wp-content/uploads/2026/07/Poster_AACR2023_Indoleamine-2-3-dioxygenase-expressed-tertiary-lymphoid-structures-associated-with-improved-outcome-lung-cancer-treated-anti-PD1-PDL1-inhibitors.jpg https://explicyte.com/wp-content/uploads/2026/07/Poster_AACR2023_Indoleamine-2-3-dioxygenase-expressed-tertiary-lymphoid-structures-associated-with-improved-outcome-lung-cancer-treated-anti-PD1-PDL1-inhibitors-pdf.jpg https://explicyte.com/wp-content/uploads/2026/07/Poster_AACR2023_Indoleamine-2-3-dioxygenase-expressed-tertiary-lymphoid-structures-associated-with-improved-outcome-lung-cancer-treated-anti-PD1-PDL1-inhibitors-pdf.jpg https://explicyte.com/wp-includes/images/media/document.png https://explicyte.com/poster/identification-of-super-exhausted-t-cells-a-novel-population-predictive-of-response-to-immunotherapy/ 2026-07-10T13:08:42+00:00 https://explicyte.com/wp-content/uploads/2026/07/PosterASCO2022_Identification-super-exhausted-T-cells-novel-population-predictive-response-immunotherapy-1024x768-1.jpg https://explicyte.com/wp-content/uploads/2026/07/PosterASCO2022_Identification-super-exhausted-T-cells-novel-population-predictive-response-immunotherapy-pdf.jpg https://explicyte.com/wp-content/uploads/2026/07/PosterASCO2022_Identification-super-exhausted-T-cells-novel-population-predictive-response-immunotherapy-pdf.jpg https://explicyte.com/wp-includes/images/media/document.png https://explicyte.com/poster/functional-evidence-for-an-immunosuppressive-role-of-kynurenine-in-cancer-patients/ 2026-07-10T12:58:48+00:00 https://explicyte.com/wp-content/uploads/2026/07/Functional-evidence-for-an-immunosuppressive-role-of-kynurenine-in-cancer-patients.jpg https://explicyte.com/wp-content/uploads/2026/07/180416-Poster-AACR-pdf.jpg https://explicyte.com/wp-content/uploads/2026/07/180416-Poster-AACR-pdf.jpg https://explicyte.com/wp-includes/images/media/document.png https://explicyte.com/poster/comprehensive-assessment-of-anti-tumor-pdl1-blockade-effect-in-a-sarcoma-mouse-model/ 2026-07-10T12:50:16+00:00 https://explicyte.com/wp-content/uploads/2026/07/Comprehensive-assessment-of-anti-tumor-PDL1-blockade-effect-in-a-sarcoma-mouse-model.jpg https://explicyte.com/wp-content/uploads/2026/07/Comprehensive-assessment-of-anti-tumor-PDL1-blockade-effect-in-a-sarcoma-mouse-model-pdf.jpg https://explicyte.com/wp-content/uploads/2026/07/Comprehensive-assessment-of-anti-tumor-PDL1-blockade-effect-in-a-sarcoma-mouse-model-pdf.jpg https://explicyte.com/wp-includes/images/media/document.png https://explicyte.com/poster/the-kynurenine-pathway-as-a-possible-resistance-mechanism-to-immunotherapy-in-sarcomas/ 2026-07-10T12:48:09+00:00 https://explicyte.com/wp-content/uploads/2026/07/The-Kynurenine-Pathway-as-a-possible-resistance-mechanism-to-immunotherapy-in-sarcomas.jpg https://explicyte.com/wp-content/uploads/2026/07/190228-Poster-AACR-2019-AB_23032019-IN-1-pdf.jpg https://explicyte.com/wp-content/uploads/2026/07/190228-Poster-AACR-2019-AB_23032019-IN-1-pdf.jpg https://explicyte.com/wp-includes/images/media/document.png https://explicyte.com/poster/ovarian-cancer-ascites-display-altered-immune-environment-featured-by-enhanced-soluble-factors-and-suppressive-cellular-context/ 2026-07-10T12:36:50+00:00 https://explicyte.com/wp-content/uploads/2026/07/Ovarian-cancer-ascites-display-altered-immune-environment-featured-by-enhanced.jpg https://explicyte.com/wp-content/uploads/2026/07/Poster-AACR-2022-Ovarian-cancer-ascites-display-altered-immune-environment-featured-enhanced-soluble-factors-suppressive-cellular-context-pdf.jpg https://explicyte.com/wp-content/uploads/2026/07/Poster-AACR-2022-Ovarian-cancer-ascites-display-altered-immune-environment-featured-enhanced-soluble-factors-suppressive-cellular-context-pdf.jpg https://explicyte.com/wp-includes/images/media/document.png https://explicyte.com/poster/low-plasma-arginine-level-is-associated-with-resistance-to-immune-checkpoint-inhibitors-in-patients-with-advanced-cancer/ 2026-07-10T12:30:15+00:00 https://explicyte.com/wp-content/uploads/2026/07/Low-plasma-Arginine-level-is-associated-with-resistance-to-immune-checkpoint-inhibitors-in-patients-with-advanced-cancer.jpg https://explicyte.com/wp-content/uploads/2026/07/Poster-AACR-2022-Low-plasma-Arginine-level-associated-resistance-immune-checkpoint-inhibitors-patients-advanced-cancer-pdf.jpg https://explicyte.com/wp-content/uploads/2026/07/Poster-AACR-2022-Low-plasma-Arginine-level-associated-resistance-immune-checkpoint-inhibitors-patients-advanced-cancer-pdf.jpg https://explicyte.com/wp-includes/images/media/document.png https://explicyte.com/poster/high-regulatory-t-cells-infiltrate-within-tertiary-lymphoid-structure-restricts-response-to-immune-checkpoint-blockers-in-sarcomas/ 2026-07-10T12:07:33+00:00 https://explicyte.com/wp-content/uploads/2026/07/High-regulatory-T-cells-infiltrate-within-tertiary-lymphoid-structure-restricts-response-to-immune-checkpoint-blockers-in-sarcomas.jpg https://explicyte.com/wp-content/uploads/2026/07/Poster-AACR-2022-High-regulatory-T-cells-infiltrate-tertiary-lymphoid-structure-restricts-response-immune-checkpoint-blockers-sarcomas-pdf.jpg https://explicyte.com/wp-content/uploads/2026/07/Poster-AACR-2022-High-regulatory-T-cells-infiltrate-tertiary-lymphoid-structure-restricts-response-immune-checkpoint-blockers-sarcomas-pdf.jpg https://explicyte.com/wp-includes/images/media/document.png https://explicyte.com/poster/development-and-characterization-of-a-novel-anti-pd1-resistant-sarcoma-mouse-model/ 2026-07-10T11:59:18+00:00 https://explicyte.com/wp-content/uploads/2026/07/Development-and-characterization-of-a-novel-anti-PD1-resistant-sarcoma-mouse-model.jpg https://explicyte.com/wp-content/uploads/2026/07/Poster-AACR-2022-Development-characterization-novel-anti-PD1-resistant-sarcoma-mouse-model-pdf.jpg https://explicyte.com/wp-content/uploads/2026/07/Poster-AACR-2022-Development-characterization-novel-anti-PD1-resistant-sarcoma-mouse-model-pdf.jpg https://explicyte.com/wp-includes/images/media/document.png https://explicyte.com/poster/anti-angiogenic-therapy-combination-with-hypoxia-regulating-agent-leads-to-improved-tumor-regression-in-a-murine-model-of-renal-carcinoma/ 2026-07-09T11:36:01+00:00 https://explicyte.com/wp-content/uploads/2026/07/AACR-2020-2-1536x864-1.jpg https://explicyte.com/wp-content/uploads/2020/04/Poster-3938-AACR-2020-pdf.jpg https://explicyte.com/wp-content/uploads/2020/04/Poster-3938-AACR-2020-pdf.jpg https://explicyte.com/wp-includes/images/media/document.png https://explicyte.com/poster/gpcr-ome-modulation-upon-pd1-pdl1-axis-blockade/ 2026-07-08T17:01:35+00:00 https://explicyte.com/wp-content/uploads/2026/07/GPCR-ome-modulation-upon-PD1-PDL1-axis-blockade.jpg https://explicyte.com/wp-content/uploads/2026/07/GPCR-ome-modulation-upon-PD1-PDL1-axis-blockade-pdf.jpg https://explicyte.com/wp-content/uploads/2026/07/GPCR-ome-modulation-upon-PD1-PDL1-axis-blockade-pdf.jpg https://explicyte.com/wp-includes/images/media/document.png